Adagene (ADAG) Competitors $1.75 +0.06 (+3.55%) Closing price 04:00 PM EasternExtended Trading$1.70 -0.05 (-2.86%) As of 05:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADAG vs. AMRN, PRTA, BNTC, HRTX, SNDL, VOR, AURA, ATXS, AVTE, and AVIRShould you be buying Adagene stock or one of its competitors? The main competitors of Adagene include Amarin (AMRN), Prothena (PRTA), Benitec Biopharma (BNTC), Heron Therapeutics (HRTX), SNDL (SNDL), Vor Biopharma (VOR), Aura Biosciences (AURA), Astria Therapeutics (ATXS), Aerovate Therapeutics (AVTE), and Atea Pharmaceuticals (AVIR). These companies are all part of the "pharmaceutical products" industry. Adagene vs. Its Competitors Amarin Prothena Benitec Biopharma Heron Therapeutics SNDL Vor Biopharma Aura Biosciences Astria Therapeutics Aerovate Therapeutics Atea Pharmaceuticals Adagene (NASDAQ:ADAG) and Amarin (NASDAQ:AMRN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Does the media favor ADAG or AMRN? In the previous week, Adagene had 2 more articles in the media than Amarin. MarketBeat recorded 3 mentions for Adagene and 1 mentions for Amarin. Amarin's average media sentiment score of 1.07 beat Adagene's score of 0.14 indicating that Amarin is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagene 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Amarin 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ADAG or AMRN? Adagene has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Comparatively, Amarin has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Do analysts recommend ADAG or AMRN? Adagene currently has a consensus target price of $8.00, indicating a potential upside of 357.14%. Amarin has a consensus target price of $12.00, indicating a potential downside of 24.15%. Given Adagene's stronger consensus rating and higher probable upside, research analysts plainly believe Adagene is more favorable than Amarin.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagene 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Amarin 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is ADAG or AMRN more profitable? Adagene has a net margin of 0.00% compared to Amarin's net margin of -41.07%. Adagene's return on equity of 0.00% beat Amarin's return on equity.Company Net Margins Return on Equity Return on Assets AdageneN/A N/A N/A Amarin -41.07%-17.21%-12.16% Which has better earnings & valuation, ADAG or AMRN? Adagene has higher earnings, but lower revenue than Amarin. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdagene$100K824.43-$33.42MN/AN/AAmarin$228.61M1.43-$82.18M-$3.64-4.35 Do insiders and institutionals have more ownership in ADAG or AMRN? 9.5% of Adagene shares are held by institutional investors. Comparatively, 22.3% of Amarin shares are held by institutional investors. 21.2% of Adagene shares are held by company insiders. Comparatively, 3.3% of Amarin shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryAdagene beats Amarin on 10 of the 14 factors compared between the two stocks. Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADAG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADAG vs. The Competition Export to ExcelMetricAdageneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.61M$2.96B$5.54B$9.41BDividend YieldN/A2.46%3.75%4.03%P/E RatioN/A8.2821.0120.09Price / Sales824.43303.17433.8199.01Price / CashN/A42.5936.1658.27Price / Book1.547.678.125.65Net Income-$33.42M-$55.28M$3.25B$257.91M7 Day Performance-8.38%2.50%0.97%2.09%1 Month Performance-10.26%11.70%7.36%11.13%1 Year Performance-31.91%4.89%31.31%18.40% Adagene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADAGAdagene2.5172 of 5 stars$1.75+3.6%$8.00+357.1%-35.2%$79.61M$100K0.00260Upcoming EarningsAMRNAmarin0.3553 of 5 stars$16.65-0.5%$12.00-27.9%+1.2%$346.43M$228.61M-4.57360Positive NewsPRTAProthena3.6168 of 5 stars$6.29-2.2%$31.50+400.8%-72.9%$346.38M$135.16M-3.02130BNTCBenitec Biopharma1.6839 of 5 stars$13.49+2.4%$23.83+76.7%+21.0%$345.72M$80K-8.9320News CoverageHigh Trading VolumeHRTXHeron Therapeutics3.5659 of 5 stars$2.15-2.3%$5.00+132.6%-42.9%$335.64M$148.52M-35.83300SNDLSNDL1.4176 of 5 stars$1.24-2.4%$3.63+192.3%-28.4%$333.73M$671.81M-4.282,516Gap UpVORVor Biopharma3.5338 of 5 stars$2.67+39.8%$5.63+110.8%+138.8%$333.64MN/A-1.62140High Trading VolumeAURAAura Biosciences2.5367 of 5 stars$6.16-6.1%$22.00+257.1%-22.8%$329.76MN/A-3.2450News CoverageATXSAstria Therapeutics1.627 of 5 stars$6.20+6.7%$30.00+383.9%-44.9%$327.88MN/A-3.3230AVTEAerovate TherapeuticsN/A$11.14+3.1%N/A-86.7%$322.89MN/A-3.7320High Trading VolumeAVIRAtea Pharmaceuticals2.7816 of 5 stars$3.64-2.7%$6.00+64.8%-10.6%$320.07MN/A-2.2170Positive News Related Companies and Tools Related Companies AMRN Competitors PRTA Competitors BNTC Competitors HRTX Competitors SNDL Competitors VOR Competitors AURA Competitors ATXS Competitors AVTE Competitors AVIR Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADAG) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Adagene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.